These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 17306669)
21. Risk of recurrent molar pregnancies following complete and partial hydatidiform moles. Eagles N; Sebire NJ; Short D; Savage PM; Seckl MJ; Fisher RA Hum Reprod; 2015 Sep; 30(9):2055-63. PubMed ID: 26202916 [TBL] [Abstract][Full Text] [Related]
22. Subsequent pregnancy outcomes after complete and partial molar pregnancy, recurrent molar pregnancy, and gestational trophoblastic neoplasia: an update from the New England Trophoblastic Disease Center. Vargas R; Barroilhet LM; Esselen K; Diver E; Bernstein M; Goldstein DP; Berkowitz RS J Reprod Med; 2014; 59(5-6):188-94. PubMed ID: 24937955 [TBL] [Abstract][Full Text] [Related]
23. Single-dose actinomycin D: Efficacy in the prophylaxis of postmolar gestational trophoblastic neoplasia in adolescents with high-risk hydatidiform mole. Uberti EM; Diestel MC; Guimarães FE; De Nápoli G; Schmid H Gynecol Oncol; 2006 Aug; 102(2):325-32. PubMed ID: 16476471 [TBL] [Abstract][Full Text] [Related]
24. Assessment of Her-2/neu expression in hydatidiform moles for prediction of subsequent gestational trophoblastic neoplasia. Menczer J; Schreiber L; Berger E; Golan A; Levy T Gynecol Oncol; 2007 Mar; 104(3):675-9. PubMed ID: 17126893 [TBL] [Abstract][Full Text] [Related]
25. Management of gestational trophoblastic neoplasia with metastasis to the central nervous system: A 12-year review at the Philippine General Hospital. Cagayan MS; Lu-Lasala LR J Reprod Med; 2006 Oct; 51(10):785-92. PubMed ID: 17086807 [TBL] [Abstract][Full Text] [Related]
26. [Gestational trophoblastic tumors and recent clinical information]. Shimizu T; Yaegashi N Gan To Kagaku Ryoho; 2002 Aug; 29(8):1363-70. PubMed ID: 12214462 [TBL] [Abstract][Full Text] [Related]
27. Risk of gestational trophoblastic neoplasia after hCG normalisation according to hydatidiform mole type. Schmitt C; Doret M; Massardier J; Hajri T; Schott AM; Raudrant D; Golfier F Gynecol Oncol; 2013 Jul; 130(1):86-9. PubMed ID: 23523617 [TBL] [Abstract][Full Text] [Related]
28. Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy. Sebire NJ; Fisher RA; Foskett M; Rees H; Seckl MJ; Newlands ES BJOG; 2003 Jan; 110(1):22-6. PubMed ID: 12504931 [TBL] [Abstract][Full Text] [Related]
29. Relapsed gestational trophoblastic neoplasia: A 20-year experience. Ngan HY; Tam KF; Lam KW; Chan KK J Reprod Med; 2006 Oct; 51(10):829-34. PubMed ID: 17086812 [TBL] [Abstract][Full Text] [Related]
30. Gestational trophoblastic neoplasia after achieving a nondetectable serum human chorionic gonadotrophin level. Gueye M; Kane-Gueye SM; Ndiaye-Gueye MD; Mbaye M; Diouf AA; Niang MM; Diallo M; Moreau JC BJOG; 2014 Oct; 121(11):1415-9. PubMed ID: 24674295 [TBL] [Abstract][Full Text] [Related]
31. Prevention of postmolar gestational trophoblastic neoplasia using prophylactic single bolus dose of actinomycin D in high-risk hydatidiform mole: a simple, effective, secure and low-cost approach without adverse effects on compliance to general follow-up or subsequent treatment. Uberti EM; Fajardo Mdo C; da Cunha AG; Rosa MW; Ayub AC; Graudenz Mda S; Schmid H Gynecol Oncol; 2009 Aug; 114(2):299-305. PubMed ID: 19427681 [TBL] [Abstract][Full Text] [Related]
32. 25 years' experience in the treatment of gestational trophoblastic neoplasia in Hungary. Szigetvári I; Szepesi J; Végh G; Bátorfi J; Arató G; Gáti I; Berkowitz RS; Fülöp V J Reprod Med; 2006 Oct; 51(10):841-8. PubMed ID: 17086814 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of the risk of persistent trophoblastic disease after twin pregnancy with diploid hydatidiform mole and coexisting normal fetus. Niemann I; Sunde L; Petersen LK Am J Obstet Gynecol; 2007 Jul; 197(1):45.e1-5. PubMed ID: 17618752 [TBL] [Abstract][Full Text] [Related]
35. [Effects of primary chemotherapy with single methotrexate on low-risk gestational trophoblastic neoplasia and influencing factors thereof]. Chen YX; Shen YM; Qian JH; Xie X Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(30):2109-12. PubMed ID: 16313819 [TBL] [Abstract][Full Text] [Related]
36. Gestational trophoblastic tumor at a tertiary level cancer center: a retrospective study. Chakrabarti BK; Mondal NR; Chatterjee T J Reprod Med; 2006 Nov; 51(11):875-8. PubMed ID: 17165433 [TBL] [Abstract][Full Text] [Related]
37. [A plea for the creation of trophoblastic disease reference centers in France]. Golfier F; Frappart L; Schott AM; Raudrant D J Gynecol Obstet Biol Reprod (Paris); 2000 Oct; 29(6):538-47. PubMed ID: 11084460 [TBL] [Abstract][Full Text] [Related]
38. Low risk of relapse after achieving undetectable HCG levels in women with partial molar pregnancy. Wolfberg AJ; Growdon WB; Feltmate CM; Goldstein DP; Genest DR; Chinchilla ME; Berkowitz RS; Lieberman ES Obstet Gynecol; 2006 Aug; 108(2):393-6. PubMed ID: 16880311 [TBL] [Abstract][Full Text] [Related]
39. Development of postmolar trophoblastic disease after partial molar pregnancy. Goto S; Yamada A; Ishizuka T; Tomoda Y Gynecol Oncol; 1993 Feb; 48(2):165-70. PubMed ID: 8428686 [TBL] [Abstract][Full Text] [Related]